Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles

AIDS Research and Human Retroviruses

Volumn 22, Issue 10, 2006, Pages 993-997

  Gupta, Soumi ^a   Zhou, Fengmin ^b   Greer, Catherine E ^b   Legg, Harold ^b   Tang, Tony ^b   Luciw, Paul ^a   Zur Megede, Jan ^b   Barnett, Susan W ^b   Donnelly, John J ^b   O'Hagan, Derek T ^b   Polo, John M ^b   Vajdy, Michael ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Novartis Vaccines and Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; GLYCOPROTEIN GP 140; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ALPHA VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELL LINEAGE; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; MACACA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REPLICON; SALIVA; SERUM; SINDBIS VIRUS; VAGINA; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CHIMERA; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; FEMALE; GENE PRODUCTS, ENV; HIV ANTIBODIES; IMMUNITY, MUCOSAL; IMMUNIZATION; INJECTIONS, INTRAMUSCULAR; MACACA MULATTA; REPLICON; SINDBIS VIRUS;

EID: 33846260242     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.993     Document Type: Article

References (15)

1. Vajdy M, Gardner J, Neidleman J, et al.: Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with Sindbis virus-based replicon particles. J Infect Dis 2001;184:1613-1616.
2. Gupta S, Janani R, Bin Q, et al.: Characterization of HIV-gag-specific IFNg-expressing cells following protective mucosal immunization with alphavirus replicon particles. J Virol 2005;79:7135-7145.
3. Giuliani MM, Del Giudice G, Giannelli V, et al.: Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med 1998;187:1123-1132.
4. Russell MW, Moldoveanu Z, White PL, et al.: Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subuntt. Infect Immun 1996;64:1272-1283.
5. Imaoka K, Miller CJ, Kubota M, et al.: Nasal immunization of non-human primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues. J Immunol 1998;161:5952-5958.
6. Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, and Mestecky J: Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 1995;13:1006-1012.
7. Bergquist C, Johansson EL, Lagergard T, Holmgren J, and Rudin A: Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997;65:2676-2684.
8. Perri S, Greer CE, Thudium K, et al.: An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector. J Virol 2003;77:10394-10403.
9. Vajdy M, Singh M, Kazzaz J, et al.: Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intra-nasal and parenteral immunizations. AIDS Res Hum Retroviruses 2004;20:1269-1281.
10. Vajdy M, Singh M, Ugozzoli M, et al.: Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations. Immunology 2003;110:86-94.
11. Mestecky J, Moldoveanu Z, and Russell MW: Immunologic uniqueness of the genital tract: Challenge for vaccine development. Am J Reprod Immunol 2005;53:208-214.
12. Klimstra WB, Nangle EM, Smith MS, Yurochko AD, and Ryman KD: DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol 2003;77:12022-12032.
13. MacDonald GH and Johnston RE: Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis. J Virol 2000;74:914-922.
14. Linn ML, Mateo L, Gardner J, and Suhrbier A: Alphavirus-specific cytotoxic T lymphocytes recognize a cross-reactive epitope from the capsid protein and can eliminate virus from persistently infected macrophages. J Virol 1998;72:5146-5153.
15. Gardner JP, Frolov I, Perri S, et al.: Infection of human dendritic cells by a Sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein. J Virol 2000;74:11849-11857.